ArticleBosnian journal of basic medical sciences2022

ORM 1 as a biomarker of increased vascular invasion and decreased sorafenib sensitivity in hepatocellular carcinoma.

Jiangning Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.